Akèy › Glakòm
Etid klinik pou Glakòm ap rekrite nan Etazini
53 etid pou Glakòm ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Baltimore, MD6 etid
- San Francisco, CA5 etid
- Boston, MA5 etid
- Durham, NC5 etid
- Mountain View, CA4 etid
- Philadelphia, PA4 etid
Pa eta
- Colorado3 etid
- Florid4 etid
- Kalifòni14 etid
- Maryland7 etid
- Massachusetts5 etid
- Michigan3 etid
- New York5 etid
- North Carolina5 etid
- Ohio3 etid
- Pennsylvania4 etid
- Texas8 etid
- Wisconsin3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
iDose TR Administration in an Office-Based Surgery Setting
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07816692Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07847073Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07075718A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07770685Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Incentives
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07755748Functional and Structural Imaging for Glaucoma
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 85 · Tout sèks · Mizajou Sep 9, 2026 · NCT01957267The Glaucoma and Retinopathy Screening Study
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06882356Clarifying the Optimal Application of SLT Therapy Trial
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT04967989Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06993597Optimize Pediatric OCT Imaging
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Aug 5, 2026 · NCT06139523Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT05924477Optic Nerve Head Strain in Non-glaucoma Subjects
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 30 a 90 · Tout sèks · Mizajou Jul 13, 2026 · NCT07425535Ocular Blood Flow Imaging for Glaucoma Assessment
Ap rekriteVolontè an sante akeyi
Laj 18 a 88 · Tout sèks · Mizajou Jul 2, 2026 · NCT05726058Stem Cell Ophthalmology Treatment Study II
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT03011541Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT07588152Village-Integrated Eye Worker Trial II
Ap rekriteVolontè an sante akeyi
Laj 60 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT03752840Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease
Ap rekriteVolontè an sante akeyi
Laj 4 a 21 · Tout sèks · Mizajou May 26, 2026 · NCT05150197Rocklatan vs Latanoprost Post-DSLT
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT07465913Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07408154Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices
Ap rekriteVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou May 6, 2026 · NCT05523622Strategies for Improving Linkage-to-Care After Eye Disease Screening
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT06943599Change in IOP Fluctuation After DSLT
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 20, 2026 · NCT07428668Glaucoma Screening to Enhance At-Risk Californians' Health
Ap rekriteVolontè an sante akeyi
Laj 50 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT06854198Glaucoma Related Quality of Life
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 6, 2026 · NCT07510087Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT07495852Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.